Indian Tuberculosis Diagnosis and Treatment Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025
Indian tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.2% during the forecast period. As per World Health Organization (WHO), A total of 1.5 million people have mortality from TB in 2018 (including 251 000 people with HIV). Across the globe, TB is one of the top 10 causes of mortality and the leading cause from a single infectious agent (above HIV/AIDS). Additionally, in 2018, an estimated 10 million people fell ill with tuberculosis (TB) across the globe.
Request a Free Sample of our Report on Indian Tuberculosis Diagnosis and Treatment Market:https://www.omrglobal.com/request-sample/indian-tuberculosis-diagnosis-treatment-market
Various government initiatives in the country are responsible for the significant growth of the market. For instance, Revised National Tuberculosis Control Program (RNTCP) is the major state-run tuberculosis (TB) control initiative of the Government of India. As per the National Strategic Plan 2012–17, this aimed to achieve a “TB free India”. The program’s major goal is to achieve Universal Access to TB control services. Moreover, it provides various free of cost, quality tuberculosis diagnosis and treatment services across the country with the enables of various government health system.
Indian tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., Biochemical and Synthetic Products Pvt Ltd, Eiken Chemical Co., Ltd., F. Hoffmann-La Roche Ltd., Labatec Pharma SA, Lupin Pharmaceuticals, Inc., Thermo Fisher Scientific and GlaxoSmithKline PLC. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
A Full Report of Indian Tuberculosis Diagnosis and Treatment Market is Available at https://www.omrglobal.com/industry-reports/indian-tuberculosis-diagnosis-treatment-market
Indian Tuberculosis Diagnosis and Treatment Market
By Drugs Type
- First Line Drugs
- Second Line Drugs
By Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- BioMérieux SA
- EPISTEM HOLDINGS PLC
- GlaxoSmithKline PLC
- Hain Lifescience GmbH
- Johnson & Johnson
- OTSUKA NOVEL PRODUCTS GMBH
- Sandoz Inc.
- Sanofi Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-tuberculosis-diagnosis-treatment-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
